Prospector Partners’s Eli Lilly LLY Stock Holding History

Prospector Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,500	Closed	-$331K	–	141
2016 Q4	$331K	Hold	4,500	–	–	0.05%	136
2016 Q3	$361K	Hold	4,500	–	–	0.06%	141
2016 Q2	$354K	Hold	4,500	–	–	0.06%	137
2016 Q1	$324K	Hold	4,500	–	–	0.06%	133
2015 Q4	$379K	Sell	4,500 -29,000	-87%	-$2.41M	0.07%	135
2015 Q3	$2.8M	Hold	33,500	–	–	0.4%	79
2015 Q2	$2.8M	Sell	33,500 -75,800	-69%	-$5.78M	0.33%	79
2015 Q1	$7.94M	Sell	109,300 -2,200	-2%	-$157K	0.6%	60
2014 Q4	$7.69M	Buy	111,500 +26,000	+30%	+$1.75M	0.58%	61
2014 Q3	$5.54M	Sell	85,500 -2,100	-2%	-$133K	0.3%	96
2014 Q2	$5.45M	Buy	+87,600	New	+$5.23M	0.26%	108

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Prospector Partners's LLY Position: Q1 2017 in Review

Prospector Partners sold out of Eli Lilly (LLY) in Q1 2017, closing a stake of 4,500 shares — an estimated $331K sold.

Prospector Partners first reported a position in LLY in Q2 2014 and held it in 11 quarters. The position peaked at $7.94M in Q1 2015. 1,250 funds tracked by Wall St. Rank hold LLY as of Q1 2017.

Prospector Partners reported no remaining Eli Lilly position as of Q1 2017 after selling out during the quarter.
Prospector Partners sold 4,500 Eli Lilly shares in Q1 2017, an estimated $331K.
Prospector Partners first reported a position in Eli Lilly in Q2 2014 and held it in 11 quarters.
Prospector Partners's Eli Lilly position peaked at $7.94M in Q1 2015.
1,250 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2017.

Based on Prospector Partners's 13F filing for Q1 2017, filed 15 May 2017.